Mei Chung1, Naisi Zhao1, Richard Meier2, Devin C Koestler2,3, Guojun Wu4, Erika de Castillo5, Bruce J Paster5,6, Kevin Charpentier7, Jacques Izard8,9, Karl T Kelsey10, Dominique S Michaud1. 1. Department of Public Health and Community Medicine, School of Medicine, Tufts University, Boston, MA, USA. 2. Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA. 3. University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS, USA. 4. Department of Biochemistry and Microbiology, Center for Nutrition, Microbiome and Health, New Jersey Institute for Food, Nutrition and Health, Rutgers University, New Brunswick, NJ, USA. 5. Department of Microbiology, The Forsyth Institute, Cambridge, MA, USA. 6. Department of Oral Medicine, Infection & Immunity, Harvard School of Dental Medicine, Boston, MA, USA. 7. Department of Surgery, Rhode Island Hospital, Providence, RI, USA. 8. Department of Food Science and Technology, University of Nebraska, Lincoln, NE, USA. 9. Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. 10. Center for Environmental Health and Technology, Brown University, Providence, RI, USA.
Abstract
Background: Oral microbiota is believed to play important roles in systemic diseases, including cancer. Methods: We collected oral samples (tongue, buccal, supragingival, and saliva) and pancreatic tissue or intestinal samples from 52 subjects, and characterized 16S rRNA genes using high-throughput DNA sequencing. Results: Bray-Curtis plot showed clear separations between bacterial communities in the oral cavity and those in intestinal and pancreatic tissue samples. PERMANOVA tests indicated that bacterial communities from buccal samples were similar to supragingival and saliva samples, and pancreatic duct samples were similar to pancreatic tumor samples, but all other samples were significantly different from each other. A total of 73 unique Amplicon Sequence Variants (ASVs) were shared between oral and pancreatic or intestinal samples. Only four ASVs showed significant concordance, and two specific bacterial species (Gemella morbillorum and Fusobacterium nucleatum subsp. vincentii) showed consistent presence or absence patterns between oral and intestinal or pancreatic samples, after adjusting for within-subject correlation and disease status. Lastly, microbial co-abundance analyses showed distinct strain-level cluster patterns among microbiome members in buccal, saliva, duodenum, jejunum, and pancreatic tumor samples. Conclusions: Our findings indicate that oral, intestinal, and pancreatic bacterial microbiomes overlap but exhibit distinct co-abundance patterns in patients with pancreatic cancer and other gastrointestinal diseases.
Background: Oral microbiota is believed to play important roles in systemic diseases, including cancer. Methods: We collected oral samples (tongue, buccal, supragingival, and saliva) and pancreatic tissue or intestinal samples from 52 subjects, and characterized 16S rRNA genes using high-throughput DNA sequencing. Results: Bray-Curtis plot showed clear separations between bacterial communities in the oral cavity and those in intestinal and pancreatic tissue samples. PERMANOVA tests indicated that bacterial communities from buccal samples were similar to supragingival and saliva samples, and pancreatic duct samples were similar to pancreatic tumor samples, but all other samples were significantly different from each other. A total of 73 unique Amplicon Sequence Variants (ASVs) were shared between oral and pancreatic or intestinal samples. Only four ASVs showed significant concordance, and two specific bacterial species (Gemella morbillorum and Fusobacterium nucleatum subsp. vincentii) showed consistent presence or absence patterns between oral and intestinal or pancreatic samples, after adjusting for within-subject correlation and disease status. Lastly, microbial co-abundance analyses showed distinct strain-level cluster patterns among microbiome members in buccal, saliva, duodenum, jejunum, and pancreatic tumor samples. Conclusions: Our findings indicate that oral, intestinal, and pancreatic bacterial microbiomes overlap but exhibit distinct co-abundance patterns in patients with pancreatic cancer and other gastrointestinal diseases.
Authors: Marcus J Claesson; Ian B Jeffery; Susana Conde; Susan E Power; Eibhlís M O'Connor; Siobhán Cusack; Hugh M B Harris; Mairead Coakley; Bhuvaneswari Lakshminarayanan; Orla O'Sullivan; Gerald F Fitzgerald; Jennifer Deane; Michael O'Connor; Norma Harnedy; Kieran O'Connor; Denis O'Mahony; Douwe van Sinderen; Martina Wallace; Lorraine Brennan; Catherine Stanton; Julian R Marchesi; Anthony P Fitzgerald; Fergus Shanahan; Colin Hill; R Paul Ross; Paul W O'Toole Journal: Nature Date: 2012-08-09 Impact factor: 49.962
Authors: Erika Del Castillo; Richard Meier; Mei Chung; Devin C Koestler; Tsute Chen; Bruce J Paster; Kevin P Charpentier; Karl T Kelsey; Jacques Izard; Dominique S Michaud Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-10-29 Impact factor: 4.254
Authors: Yanjiao Zhou; Hongyu Gao; Kathie A Mihindukulasuriya; Patricio S La Rosa; Kristine M Wylie; Tatiana Vishnivetskaya; Mircea Podar; Barb Warner; Phillip I Tarr; David E Nelson; J Dennis Fortenberry; Martin J Holland; Sarah E Burr; William D Shannon; Erica Sodergren; George M Weinstock Journal: Genome Biol Date: 2013-01-14 Impact factor: 13.583
Authors: Pedro J Torres; Erin M Fletcher; Sean M Gibbons; Michael Bouvet; Kelly S Doran; Scott T Kelley Journal: PeerJ Date: 2015-11-05 Impact factor: 2.984
Authors: Tomas Koltai; Stephan Joel Reshkin; Tiago M A Carvalho; Daria Di Molfetta; Maria Raffaella Greco; Khalid Omer Alfarouk; Rosa Angela Cardone Journal: Cancers (Basel) Date: 2022-05-18 Impact factor: 6.575
Authors: Kelly M Herremans; Andrea N Riner; Miles E Cameron; Kelley L McKinley; Eric W Triplett; Steven J Hughes; Jose G Trevino Journal: Microbiome Date: 2022-06-15 Impact factor: 16.837
Authors: Nabeel Merali; Tarak Chouari; Kayani Kayani; Charles J Rayner; José I Jiménez; Jonathan Krell; Elisa Giovannetti; Izhar Bagwan; Kate Relph; Timothy A Rockall; Tony Dhillon; Hardev Pandha; Nicola E Annels; Adam E Frampton Journal: Cancers (Basel) Date: 2022-02-17 Impact factor: 6.639